4DMEDICAL LTD. Aktie Logo
AU0000095416
A2QAMP
4DX.AX

4DMEDICAL LTD. Aktie

Loading quotes...

Forecast

There is no analyst data available for this company.

Discussions in the community

There is no discussion about this asset yet.

Start discussion

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics
In 2025, 4DMEDICAL LTD. Aktie has already paid €0.0198 in dividends. The last payout was in September 2025.

Financials

In the last quarter, 4DMEDICAL LTD. Aktie had revenue of €2.55M and net profit of -€30.46M
(EUR) June 2026
YoY
Revenue 2.55M -
Gross profit -11.85M -
Net profit -30.46M -
EBITDA -17.09M -

Fundamentals

Metric Value
Market capitalization
€850.21M
Number of shares
602.34M
52-week high/low
€4.63 - €0.86
Dividends No
Beta
1.84
P/E ratio
-5.83
PEG ratio
0.01
P/B ratio
8.07
P/S ratio
196.19

Company profile

4DMedical Limited operates as a medical technology company in Australia and the United States. It commercializes XV Technology, a four-dimensional lung imaging technology. The company also offers software as a service delivery model; XV lung ventilation analysis software; Permetium, a preclinical imaging system which quantify regional changes in pulmonary function; and AccuVent 200, a small animal ventilator. The company was incorporated in 2012 and is based in Carlton, Australia.

Name
4DMEDICAL LTD. Aktie
CEO
Andreas Fouras
Headquarters Carlton, vic
Australia
Website
IPO
08/07/2020
Employees 181

Ticker symbols

Exchange Symbol
Australian Securities Exchange Ltd
4DX.AX
Pnk
FDMDF
🍪

Parqet  uses cookies. Learn more